{{Drugbox
| IUPAC_name = 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1''H''-indazole-3-carboxamide
| image = 5F-CUMYL-PINACA.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = PSA
| legal_US = 
| legal_status = Illegal in Sweden
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 1400742-16-6
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 86274158
| ChemSpiderID = 35228406


<!--Chemical data-->
| C=22 | H=26 | F=1 | N=3 | O=1
| molecular_weight = 367.5 g/mol
| smiles            = O=C(NC(C)(C)C1=CC=CC=C1)C2=NN(CCCCCF)C3=C2C=CC=C3
| StdInChI          = 1S/C22H26FN3O/c1-22(2,17-11-5-3-6-12-17)24-21(27)20-18-13-7-8-14-19(18)26(25-20)16-10-4-9-15-23/h3,5-8,11-14H,4,9-10,15-16H2,1-2H3,(H,24,27)
| StdInChIKey       = XSHGVIPHMOTDCS-UHFFFAOYSA-N
}}

'''5F-CUMYL-PINACA''' (also known as '''SGT-25''' and sometimes sold in [[e-cigarette]] form as '''C-Liquid''')<ref>{{cite web | url=https://www.uniklinik-freiburg.de/fileadmin/mediapool/08_institute/rechtsmedizin/pdf/Poster_2015/Angerer_V_-_5F-cumyl-PINACA_in_e-liquids_for_electronic_cigarettes_-_2015.pdf | title=5F-cumyl-PINACA in 'e-liquids' for electronic  cigarettes – A new type of synthetic  cannabinoid in a trendy product | publisher=Institute of Forensic Medicine, Forensic Toxicology, Medical Center – University of Freiburg, Germany | date=2015 | author1=Verena Angerer | author2=Bjoern Moosmann | author3=Florian Franz | author4=Volker Auwärter}}</ref> is an [[indazole]]-3-carboxamide based [[synthetic cannabinoid]].<ref>{{cite web | url=https://www.caymanchem.com/Product.vm/catalog/17726 | title=5F-CUMYL-PINACA | publisher=Cayman Chemical | accessdate=11 July 2015}}</ref> 5F-CUMYL-PINACA acts as a potent [[agonist]] for the [[cannabinoid receptor]]s, with the original patent claiming approximately 4x selectivity for [[CB1 receptor|CB<sub>1</sub>]], having an EC<sub>50</sub> of <0.1 nM for human [[Cannabinoid receptor type 1|CB<sub>1</sub> receptors]] and 0.37nM for human [[Cannabinoid receptor type 2|CB<sub>2</sub> receptors]].<ref>{{cite web | url=https://www.google.com/patents/WO2014167530A1 | title=Patent WO 2014167530 - Cannabinoid compounds | work=New Zealand Patent application 623626 | date=11 April 2013 | accessdate=11 July 2015 | author=Bowden|display-authors=etal}}</ref> In more recent assays using different techniques, 5F-CUMYL-PINACA was variously found to have an EC<sub>50</sub> of 0.43nM at CB<sub>1</sub> and 11.3nM at CB<sub>2</sub>, suggesting a somewhat higher CB<sub>1</sub> selectivity of 26x,<ref>Longworth M, Banister SD, Boyd R, Kevin RC, Connor M, McGregor IS, Kassiou M. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues. ''ACS Chem Neurosci''. 2017 Aug 11. {{doi|10.1021/acschemneuro.7b00267}} {{PMID|28792725}}}</ref> or alternatively 15.1nM at CB<sub>1</sub> and 34.8nM at CB<sub>2</sub> with only 2.3x selectivity, however these figures cannot be directly compared due to the different assay techniques used in each case.<ref>Asada A, Doi T, Tagami T, Takeda A, Satsuki Y, Kawaguchi M, Nakamura A, Sawabe Y. Cannabimimetic activities of cumyl carboxamide-type synthetic
cannabinoids. ''Forensic Toxicol''. 2017. {{doi|10.1007/s11419-017-0374-9}}</ref>

== Legal status ==

Sweden's public health agency suggested classifying 5F-CUMYL-PINACA as a hazardous substance on November 10, 2014.<ref>{{cite web | url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider föreslås bli klassade som hälsofarlig vara |date= 10 November 2014 |publisher= [[Public Health Agency of Sweden]] | accessdate=11 July 2015 |trans_title= Cannabinoids suggested classified as health endangering substance |language=sv}}</ref>

==See also==
* [[5F-SDB-006]]
* [[CUMYL-PICA]]
* [[CUMYL-PINACA]]
* [[CUMYL-THPINACA]]
* [[SDB-006]]
* [[NNE1]]

==References==
{{Reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Indazolecarboxamides]]
[[Category:Fluoroalkanes]]

{{cannabinoid-stub}}